| Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
|---|
| 03/28/2001 | EP1085894A1 Beta 3-adrenergic receptor agonists |
| 03/28/2001 | EP1085893A1 Phosphodiesterase-v modulator drugs and their uses |
| 03/28/2001 | EP1085891A1 Multibinding inhibitors of topoisomerase |
| 03/28/2001 | EP1085889A2 Novel therapeutic agents that modulate endothelin receptors |
| 03/28/2001 | EP1085887A2 Novel angiotensin receptor modulators and their uses |
| 03/28/2001 | EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists |
| 03/28/2001 | EP1085861A1 Inhibitors of nitric oxide synthase |
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors |
| 03/28/2001 | EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/28/2001 | EP1085845A2 Multibinding inhibitors of cyclooxygenase-2 |
| 03/27/2001 | US6207831 A benzopyrazole compound |
| 03/27/2001 | US6207698 For therapy of osteoarthritis, rheumatoid arthritis, corneal ulceration, periodontitis, metastasis and invasion of tumor, and virus infection |
| 03/27/2001 | US6207697 Amidinyl-substituted rings; anticoagulants; thromboembolic disorders; antiischemic and antiinflammatory agents; strokes; serine protease inhibitors |
| 03/27/2001 | US6207693 Benzamide derivatives having a vasopressin antagonistic activity |
| 03/27/2001 | US6207663 Vitronectin receptor antagonists, their preparation and use |
| 03/27/2001 | CA2104196C Methods of combating pneumocystis carinii pneumonia and compounds useful therefor |
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors |
| 03/21/2001 | EP1083921A1 Novel leukotriene receptor antagonists and their uses |
| 03/21/2001 | EP1083920A1 Novel antibacterial compounds |
| 03/21/2001 | EP1083919A1 Novel antiviral compounds |
| 03/21/2001 | EP1083917A1 Novel analgesic agents |
| 03/21/2001 | EP1083894A1 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE |
| 03/21/2001 | EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors |
| 03/21/2001 | EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS |
| 03/21/2001 | EP0938310A4 Anti-viral compounds |
| 03/21/2001 | CN1288461A Process for preparing sparingly soluble aromatic amines |
| 03/21/2001 | CN1063430C Ethanolamine derivatives |
| 03/20/2001 | US6204293 Inhibitors of protein isoprenyl transferases |
| 03/20/2001 | US6204282 Benzimidazole compounds that are vitronectin receptor antagonists |
| 03/20/2001 | US6204278 Anilide compounds, including use thereof in ACAT inhibitition |
| 03/20/2001 | US6204264 Benzimidazole derivative, hair growth promoter and external composition for skin using the same |
| 03/20/2001 | US6203580 Oxidative dyeing |
| 03/15/2001 | WO2001017982A1 Benzophenones as inhibitors of reverse transcriptase |
| 03/15/2001 | WO2001017968A1 Integrase inhibitors containing aromatic heterocycle derivatives |
| 03/15/2001 | WO2000058286A3 Method of producing heterocyclic carbamates from aza-heterocyclic compounds and carbon dioxide |
| 03/15/2001 | WO1999065870A3 Sulfonamide inhibitors of aspartyl protease |
| 03/15/2001 | CA2383782A1 Compounds for the treatment of viral infections |
| 03/14/2001 | EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors |
| 03/14/2001 | EP1082127A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
| 03/14/2001 | EP1082110A1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 03/13/2001 | US6200971 For treating atherosclerosis |
| 03/08/2001 | WO2001016113A1 Traceless solid phase synthesis of aromatic and heteroaromatic compounds |
| 03/08/2001 | WO2001016097A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 03/08/2001 | WO1999064047A8 Novel antiviral compounds |
| 03/08/2001 | WO1999063930A8 Novel angiotensin receptor modulators and their uses |
| 03/08/2001 | CA2382789A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 03/07/2001 | EP1081146A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 03/07/2001 | EP1081144A2 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 03/07/2001 | EP1081143A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 03/07/2001 | EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors |
| 03/07/2001 | EP1080078A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 03/07/2001 | EP1080069A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase |
| 03/07/2001 | EP1080066A1 Bioreductive cytotoxic agents |
| 03/07/2001 | EP1079830A1 BENZIMIDAZOLE ANALOGS AS DOWN-REGULATORS OF IgE |
| 03/07/2001 | CN1286251A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system |
| 03/07/2001 | CN1286250A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system |
| 03/06/2001 | US6197968 Storage stability; colorless after solution treatment |
| 03/06/2001 | US6197791 N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 03/06/2001 | US6197750 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/01/2001 | WO2001014375A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 03/01/2001 | WO2001014367A1 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 03/01/2001 | WO2001014355A1 Substituted piperazine derivatives, the production thereof and their utilization as medicaments |
| 03/01/2001 | WO2001014343A1 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase |
| 03/01/2001 | WO2001014342A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments |
| 03/01/2001 | WO2001014338A1 NOVEL INTEGRIN αVβ3 INHIBITORS |
| 03/01/2001 | WO2001014337A1 αvβ3 INTEGRIN INHIBITORS |
| 03/01/2001 | DE19939981A1 Neue Inhibitoren des Integrins alphavß3 New inhibitors of integrin alphavß3 |
| 03/01/2001 | DE19939980A1 Inhibitoren des Integrins alphavbeta¶3¶ Inhibitors of integrin alphavbeta¶3¶ |
| 03/01/2001 | CA2382867A1 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 03/01/2001 | CA2382850A1 Novel inhibitors of the integrin .alpha.v.beta.3 |
| 03/01/2001 | CA2382561A1 Inhibitors of integrin .alpha.v.beta.3 |
| 03/01/2001 | CA2382311A1 Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
| 03/01/2001 | CA2376293A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 02/28/2001 | EP1078917A1 Amidino derivatives and drugs containing the same as the active ingredient |
| 02/28/2001 | EP1077967A2 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077928A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077927A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077700A1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE |
| 02/28/2001 | EP1077695A2 COMPOUNDS HAVING IgE AFFECTING PROPERTIES |
| 02/28/2001 | CN1285820A Metabotropic glutamate receptor antagonists for treating central nervous system disease |
| 02/28/2001 | CA2317097A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/28/2001 | CA2317001A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/28/2001 | CA2316748A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/27/2001 | US6194447 Bis (benzimidazole) derivatives serving as potassium blocking agents |
| 02/27/2001 | US6194414 Radioprotectors |
| 02/27/2001 | US6194396 Benzimidazole compounds as bradykinin antagonists |
| 02/27/2001 | US6194132 Photographic element, compound, and process |
| 02/22/2001 | WO2001012600A1 INHIBITORS OF FACTOR Xa |
| 02/22/2001 | WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 02/22/2001 | DE19939516A1 New 1-carboxyalkyl-4-(hetero)aryl-piperazine derivatives, as microsomal triglyceride transfer protein inhibitors useful for reducing plasma atherogenic lipoprotein levels, e.g. in treatment of hyperlipidemia |
| 02/22/2001 | DE19939463A1 Tryptase inhibitors useful e.g. for treating inflammatory or allergic disease, arteriosclerosis or neoplasia, comprising new or known 2-phenethyl-benzimidazole-5-carboxamides |
| 02/21/2001 | CN1284944A Integrin receptor antagonists |
| 02/21/2001 | CN1284868A Oral pharmaceutical pulsed release dosage form |
| 02/21/2001 | CN1284866A Oral pharmaceutical extended release dosage form |
| 02/20/2001 | US6191157 Anticholesterol agents; cardiovascular disorders |
| 02/15/2001 | WO2001010842A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/15/2001 | WO2001010841A2 Fluorene derivatives as integrin inhibitors |
| 02/15/2001 | WO2001010799A1 Methods for preparing n-[(aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds |
| 02/15/2001 | CA2381008A1 Melanocortin-4 receptor binding compounds and methods of use thereof |